MPI Research Presents Annual Educational Summit - Advances in Therapeutic Discovery & Drug Development: Preclinical Cell-Based Therapy Research
Posted on: Wednesday, 18 July 2007, 09:19 CDT
MPI Research, a preclinical contract research organization that sponsors annual educational summits, is proud to present, Advances in Therapeutic Discovery and Drug Development: Preclinical Cell-Based Therapy Research, August 15-17, 2007 at the historic and picturesque Brook Lodge in Augusta, Michigan. This year's summit cosponsor is WiCell Research Institute, home to the National Stem Cell Bank and supporter of the University of Wisconsin-Madison, known as a world leader in hES cell research. With a speaker dais of fifteen world-renowned experts from industry, regulatory, and academia, the summit will feature the latest developments in the use of cell-based therapy in drug discovery research.
Summit attendees will learn about recent advances in specific therapeutic areas, including cardiology, neurology, endocrinology, and oncology. Presentations will also be made on cell imaging, preclinical study design, regulatory considerations, and GMP issues. Those attending will have ample opportunity to have tactical and strategic discussions individually and collectively with the panel of esteemed presenters about how preclinical cell-based therapy impacts their own journeys along the path to therapeutic approvals.
"We make learning and innovation a top priority in our company," said summit facilitator, Jia En Chin, PhD, Director of Drug Discovery Services at MPI Research. "Our annual summit provides a forum for scientists from the private and public sectors as well as universities to share perspectives and learn about key developments in their field. It is a dynamic, exciting environment and I am pleased that MPI Research sponsors such an event."
To assure an optimal learning environment, registration for this summit is limited and pre-registration is required. There will be no on-site registration. The summit fee is $750 and includes all meals. Visit www.mpiresearch.com/summit_program.asp to learn more about the summit, or contact Marie Warren (marie.warren@mpiresearch.com or 269-668-3336, ext. 1968), who will assist with registration and in making lodging arrangements.
MPI Research serves the preclinical research needs of pharmaceutical and biotechnology companies around the world, in bringing their products to market. Learn more information about the company at www.mpiresearch.com.
Source: Business Wire
Related Articles
- Myriad Genetics Acquires Novel Therapeutic Drug Management Technology From Saladax Biomedical
- Medarex Reports Preclinical Data on Multiple Antibody-Drug Conjugate Candidates at American Association for Cancer Research Meeting
- Seattle Genetics Presents Preclinical Data on Its Antibody-Drug Conjugate Technology and SGN-33 Program at AACR
- NIH to Sponsor Preclinical Study of DiaKine Diabetes Drug
- Developments in Stem Cell Research - Progenitor Cells Inspire a Therapy for Renal Failure
- Cytori Therapeutics Names John Ransom, Ph.D., Vice President of Research, Regenerative Cell Technology
- OSEL In-Licenses Therapeutic Drug Product From Japan
- Use of Therapeutic Drug Monitoring for Multidrug-Resistant Tuberculosis Patients*
- Use of Therapeutic Drug Monitoring in Tuberculosis Patients
- Arel CEO to Participate on Industry Panel With Avaya, Cisco, Microsoft and WebEx About Trends in Rich-Media Conferencing at Wainhouse Research Summit, July 14-16 in Boston, MA
User Comments (0)

RSS Feeds